Description and Analysis of the VA National Formulary

PAPERBACK
$77.75

Download

Table of Contents
Front Matter R1-R18
Executive Summary 1-10
Introduction 11-36
Is the VA National Formulary Overly Restrictive and Does it Prevent Physicians from Meeting the Health Care Needs of Veterans? 37-71
What are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs? 72-119
What are the Effects of the National Formulary and Related Policies on Quality of Care? 120-148
How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other Government Formularies? 149-182
The VA National Formulary and Veterans Health Care 183-200
References 201-216
Acronyms 217-220
Appendix A: Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the Congress of the United States 221-226
Appendix B: Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey 227-230
Appendix C: Additional Cost Information 231-249
Appendix D: Glossary 250-253
Appendix E: Drug Classes and Drug Index 254-258
Appendix F: Committee Biographies 259-262

Zimmerman DL, Daley J. Using Outcomes to Improve Health Care Decision Making . Boston: Department of Veterans Affairs, Office of Research and Development ; 1997.

Zoeller J. Does therapeutic interchange hurt patients? Am. Druggist. 1991; 66–79.

Table of Contents

Front Matter R1-R18

Executive Summary 1-10

Introduction 11-36

Is the VA National Formulary Overly Restrictive and Does it Prevent Physicians from Meeting the Health Care Needs of Veterans? 37-71

What are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs? 72-119

What are the Effects of the National Formulary and Related Policies on Quality of Care? 120-148

How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other Government Formularies? 149-182

The VA National Formulary and Veterans Health Care 183-200

References 201-216

Acronyms 217-220

Appendix A: Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the Congress of the United States 221-226

Appendix B: Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey 227-230

Appendix C: Additional Cost Information 231-249

Appendix D: Glossary 250-253

Appendix E: Drug Classes and Drug Index 254-258

Appendix F: Committee Biographies 259-262